| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 37,852,000 | 39,082,000 | 38,411,000 | 46,213,000 | | Cost of Revenue | 20,805,000 | 18,804,000 | 18,066,000 | 22,913,000 | | | Gross Profit | 17,047,000 | 20,278,000 | 20,345,000 | 23,300,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,676,000 | 14,865,000 | 10,083,000 | 10,704,000 | | Non Recurring | 8,021,000 |
-
|
-
|
-
| | Others |
-
| (2,336,000) | 2,336,000 | (4,453,000) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,350,000 | 7,749,000 | 7,926,000 | 17,049,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (8,319,000) | | Earnings Before Interest And Taxes | 6,350,000 | 7,749,000 | 7,926,000 | 8,591,000 | | Interest Expense | 4,322,000 | 4,653,000 | 5,327,000 | 6,106,000 | | Income Before Tax | 2,028,000 | 3,096,000 | 2,599,000 | 2,485,000 | | Income Tax Expense | (467,000) | 219,000 | (318,000) | (1,382,000) | | Minority Interest | (5,000) | (97,000) |
-
| (139,000) | | | | Net Income From Continuing Ops | 2,592,000 | 2,780,000 | 2,917,000 | 3,867,000 | | | Non-recurring Events | | Discontinued Operations | 40,000 | (194,000) | (21,000) | (145,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,530,000 | 2,586,000 | 2,896,000 | 3,722,000 | | Preferred Stock And Other Adjustments | (75,000) | 10,000 | (160,000) | (75,000) | | | Net Income Applicable To Common Shares | $2,455,000 | $2,596,000 | $2,736,000 | $3,647,000 |
|
1.23% Nasdaq 
Income Statement
